Immunotherapy Today

Immunotherapy News From Around The World

Immunotherapy could stop prostate cancer spreading, trial shows

Posted by btwatson on June 3, 2018 12:09 pm
Tags:
Categories: Uncategorized

Source: Immunotherapy could stop prostate cancer spreading, trial shows

[unable to retrieve full-text content]

  1. Immunotherapy could stop prostate cancer spreading, trial shows  The Guardian
  2. Immunotherapy prostate cancer drug gives ‘amazing results’  Sky News
  3. ASCO 2018: Major trial is first to show benefits of immunotherapy in some men with prostate cancer  The Institute of Cancer Research
  4. Full coverage

Published at Sat, 02 Jun 2018 17:51:00 +0000

< Immunotherapy Today home

Immunotherapy News

  • Leukogene Therapeutics Receives Strategic Funding from South Carolina Research Authority to Accelerate Development of Its Cancer Immunotherapy Pipeline - Markets Financial Content
    November 12, 2025
  • Global Brain Tumor Treatment Market to Surpass USD 6.22 Billion by 2033, Driven by Rise in Targeted Therapies and Immunotherapy Adoption - facilitiesmanagement-now.com
    November 12, 2025
  • How the Gut Microbiome Helps the Immune System Fight Melanoma - Technology Networks
    November 12, 2025
  • The nerve to fight cancer - Queen's University
    November 12, 2025
  • What if the COVID-19 vaccine could save cancer patients too? - The Japan Times
    November 12, 2025
  • Stage IV melanoma survivor: An immunotherapy clinical trial saved my life - MD Anderson Cancer Center
    November 12, 2025
  • Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer - CancerNetwork
    November 11, 2025
  • Analyzing Nivolumab and Ipilimumab as HCC Therapy - Targeted Oncology
    November 11, 2025
  • ELI-002 7P Elicits Robust T-Cell Responses in KRAS+ Pancreatic Cancer - CancerNetwork
    November 11, 2025
  • Locoregional therapy combined with targeted therapy and immunotherapy for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis - Nature
    November 11, 2025

Immunotherapy News from China

  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …Announces Off-the-Shelf CAR T-cell Cancer Immunotherapy to…
  • UPDATE 2-U.S. FDA approves Merck immunotherapy/chemo combo …
  • …in Combination With Anti-PD-L1 Cancer Immunotherapy and …
  • …Dosed in First-in-Human Clinical Study of Immunotherapy …
  • JITC tumor and cancer immunotherapy papers collection
    JITC tumor and cancer immunotherapy papers collection
  • Welcome to the submission|Journal for ImmunoTherapy of Cancer
  • Immunotherapy shows promise for advanced lymphoma: study
  • …from the Monotherapy Arm at the Phacilitate Immunotherapy …
  • Allergy Immunotherapy Market to exceed US$ 3.33 Bn by 2025 …
  • Load more [+]

Copyright 2018 ImmunoTherapyToday.com